Noubar Afeyan - May 12, 2022 Form 4 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role
Director, 10%+ Owner
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Stock symbol
RUBY
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
5/13/2022, 04:24 PM
Previous filing
May 13, 2022
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RUBY Stock Option (Right to Buy) Award $0 +25K $0.00 25K May 12, 2022 Common Stock 25K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service.